What question did this study set out to answer?

This research aims to evaluate the accuracy of clinical diagnosis for Parkinson disease (PD) and necessitate improvements in diagnostic methods.

January 14, 2016

Accuracy of clinical diagnosis of Parkinson disease

Key Points

This research aims to evaluate the accuracy of clinical diagnosis for Parkinson disease (PD) and necessitate improvements in diagnostic methods.
Analyzed clinical diagnosis validity over 25 years for early-stage PD.
Considered misclassification rates in determining sample size for studies.
Highlighted the importance of imaging and biomarkers for in vivo diagnosis.
Clinically diagnosed Parkinson disease showed significant misclassification, particularly in early stages.
No improvement in diagnostic accuracy over the last 25 years.
Emphasized the urgent need for imaging and biomarkers to enhance diagnostic precision.

Abstract

The overall validity of clinical diagnosis of PD is not satisfying. The accuracy did not significantly improve in the last 25 years, particularly in the early stages of disease, where response to dopaminergic treatment is less defined and hallmarks of alternative diagnoses such as atypical parkinsonism may not have emerged. Misclassification rate should be considered to calculate the sample size both in observational studies and randomized controlled trials. Imaging and biomarkers are urgently needed to improve the accuracy of clinical diagnosis in vivo.

Accuracy of clinical diagnosis of Parkinson disease

Key Points

Abstract

Cite This Study

Also Consider

Also Consider